CoreCap Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

CoreCap Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01K	Buy	+24	New	+$764	﹤0.01%	2692
2026 Q1	–	Sell	-16	Closed	-$464	–	2944
2025 Q4	$464	Sell	16 -37	-70%	-$1.11K	﹤0.01%	2715
2025 Q3	$1.47K	Hold	53	–	–	﹤0.01%	2428
2025 Q2	$1.29K	Hold	53	–	–	﹤0.01%	2386
2025 Q1	$1.1K	Hold	53	–	–	﹤0.01%	2502
2024 Q4	$1.25K	Hold	53	–	–	﹤0.01%	2332
2024 Q3	$1.36K	Hold	53	–	–	﹤0.01%	2228
2024 Q2	$1.24K	Sell	53 -51	-49%	-$1.29K	﹤0.01%	1375
2024 Q1	$2.99K	Buy	+104	New	+$3.13K	﹤0.01%	2036
2022 Q4	$3.39K	Buy	+120	New	+$3.81K	﹤0.01%	1839
2022 Q3	–	Sell	-252	Closed	-$8K	–	626
2022 Q2	$8K	Buy	+252	New	+$8.81K	﹤0.01%	1526
2022 Q1	–	Sell	-252	Closed	-$15K	–	636
2021 Q4	$15K	Buy	+252	New	+$17.4K	﹤0.01%	1404

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CoreCap Advisors's ARKG Position: Q2 2026 in Review

CoreCap Advisors opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 24 shares worth $1.01K. The stake represents ﹤0.01% of the portfolio and ranks #2692 among its holdings. This is a return to the name: CoreCap Advisors previously reported a position in ARKG as recently as Q4 2025.

CoreCap Advisors first reported a position in ARKG in Q4 2021 and has held it in 12 quarters since. The position peaked at $15K in Q4 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

CoreCap Advisors held 24 shares of ARK Genomic Revolution ETF worth $1.01K as of Q2 2026.
ARK Genomic Revolution ETF was a new CoreCap Advisors position in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2692 holding.
CoreCap Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2021 and has held it in 12 quarters since.
CoreCap Advisors's ARK Genomic Revolution ETF position peaked at $15K in Q4 2021.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.